2016
DOI: 10.1371/journal.pone.0149832
|View full text |Cite
|
Sign up to set email alerts
|

The Curcumin Analog C-150, Influencing NF-κB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo

Abstract: C-150 a Mannich-type curcumin derivative, exhibited pronounced cytotoxic effects against eight glioma cell lines at micromolar concentrations. Inhibition of cell proliferation by C-150 was mediated by affecting multiple targets as confirmed at transcription and protein level. C-150 effectively reduced the transcription activation of NFkB, inhibited PKC-alpha which are constitutively over-expressed in glioblastoma. The effects of C-150 on the Akt/ Notch signaling were also demonstrated in a Drosophila tumorigen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
37
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(37 citation statements)
references
References 53 publications
0
37
0
Order By: Relevance
“…The curcumin analog C150 significantly and markedly reduces neuronal cell death and DNA mutation in brain tissue by suppressing NF‐κβ (Hackler et al . ). Similarly, increased levels of omega‐3 polyunsaturated fatty acid (eicosapentaenoic acid) in the brain of mice also reduces the inflammatory response to LPS challenge via NF‐κβ pathways.…”
Section: Therapeutic Potential Of Biological Compounds Against Nf‐κβ–mentioning
confidence: 97%
“…The curcumin analog C150 significantly and markedly reduces neuronal cell death and DNA mutation in brain tissue by suppressing NF‐κβ (Hackler et al . ). Similarly, increased levels of omega‐3 polyunsaturated fatty acid (eicosapentaenoic acid) in the brain of mice also reduces the inflammatory response to LPS challenge via NF‐κβ pathways.…”
Section: Therapeutic Potential Of Biological Compounds Against Nf‐κβ–mentioning
confidence: 97%
“…Legumain targeted nanoparticles encapsulating hydrazinocurcumin suppressed STAT3 and re-educated TAMs, to be IL-12 high , IL-10 low and TGF-β low , which resulted in suppression of tumor growth, metastasis and angiogenesis in vivo [160]. Several new curcumin derivatives have been synthesized and were confirmed to have anticancer activities, however their potential effects on TAMs and MDSCs would be interesting to test [161]. Another inhibitor of JAK1 and STAT3, a synthetic triterpenoid, bardoxolone methyl (C-28 methyl ester of 2-cyano-3,12-dioxooleana-1,9,-dien-28-oic acid, also known as CDDO-Me) abrogated the immune suppressive effect of MDSCs on CD8+ cytotoxic T-cells resulting in decreased tumor growth in mice [162,163].…”
Section: Therapeutic Interventions Targeting Tams and Mdscs Tuninmentioning
confidence: 99%
“…A time-dependent decrease in cell area and an increase in maximum thickness was seen [31]. DH microscopy was also used to analyze the effect of the cell death-inducing curcumin analog C-150 [32]. Four different glioblastoma cell lines were treated with 1 μM of the analog for 24 h. The results showed significantly increased cell volume and average thickness and decreased cell area for the cell lines investigated.…”
Section: Cell Death Of Adherent Cellsmentioning
confidence: 99%